Erlend Bremertun
Smeland
Mini CV
Education
1980: MD, Univ. of Oslo
1980, ECFMG-exam, Copenhagen
Positions
1996 – date, Scientific director, Council for Translational Researh
2003 – date, Director, Institute for Cancer Research
1998 - date, Professor II in experimental hematology/stem cell transplantation, Medical Faculty, University of Oslo
Research interests/projects
Previous employments
Assignments/duties
The Norwegian Radium Hospital:
External tasks
Administrative experience
I have had administrative responsibility for Lab.for Immunology/Dept. of Immunology, The Norwegian Radium Hospital from 1986 to 2003. Section for Immunotherapy was included in the department in 1995 and there are now more than 30 persons employed at Department of Immunology. Approximately 2/3 of the budget for salaries, expenses and equipment are obtained from external sources. During this period I have together with Steinar Funderud had the scientific responsibility for the department. I have also been Head for the Council for Research and Development at the Norwegian Radium Hospital from 1996. The Council is an institutional council which co-ordinates research and development between the Institute for cancer research, the clinic and the industry. The Council for Research and Development is responsible for establishment and evaluation of priority areas of research and development at our institution that include high-dose therapy/stem cell therapy, detection of micrometastases, photodynamic therapy/photochemical internalisation, immunotherapy, gene therapy, clinical research unit/clinical pharmacology, radiation biology.
Research evaluation
1980: MD, Univ. of Oslo
1980, ECFMG-exam, Copenhagen
Positions
1996 – date, Scientific director, Council for Translational Researh
2003 – date, Director, Institute for Cancer Research
1998 - date, Professor II in experimental hematology/stem cell transplantation, Medical Faculty, University of Oslo
Research interests/projects
- Studies of regulation of growth and differentiation of normal and neoplastic B-cells
- signal transduction; role of protein kinases
- effect and production of cytokines - Expression profiling of normal and neoplastic B cells
- Use of SEREX-technology and phage display technology to characterise tumor antigens
Previous employments
- Practical training (turnustjeneste), Narvik Hospital, July 1980-June 1981.
- General practice (district service) Førde, July 1981-January 1982
- Medical doctor, Hormone Laboratory, Aker Hospital, Januar–June 1982.
- Military service, Institute of Aviation Medicine, University of Oslo, July 1982–March 1983.
- Research fellow, The Norwegian Cancer Society, March 1983-October 1987
- Researcher at The Norwegian Cancer Society, October 1987, April 1988.
- Deputy Head, Laboratory for Immunology, The Norwegian Radium Hospital, May 1988-September 1992
- Head, Department of Immunology, The Norwegian Radium Hospital, December 1992-2002.
Assignments/duties
The Norwegian Radium Hospital:
- Board Member, Institute for Cancer Research, 1992- 2000.
- Deputy representative, the Board of The Norwegian Radium Hospital
- Co-ordinator, The Stem Cell Project 1990-1996, (Institutional high priority area of research and development).
- Member, Advisory Board for High Dose Therapy/Stem Cell Project (1992, to date)
- Member, Council for Research and Development, DNR from 1992
- Member of working group for the Committee for Research and Development,1993 – date
- Head, Committee for Research and Development, May 1996 – date.
- Member, Board for the Radium Hospital Research Foundation, 1997 to date.
- Member, Educational Committee, 1995- 97
- Member, Planning and Strategy Committee, 1995-1996
- Member, Building and Development Programme, 1997 to date.
- Member, Organisation Committee, 1998- January 1999
- Member, Working group for Vestenghaugen- project- 1997 – 1998
- Head, Committee for reorganisation of Institute for Cancer Research, 1999-2000.
- Director, Institute for Cancer Research
- Member, Coordinating Comittee – NRH/Rikshospitalet, 2004
External tasks
- National co-ordinator for immunophenotyping of childhood leukemias in the Nordic countries, 1991-2000.
- Deputy member of the Board of the Norwegian Society for Immunology, 1992 to date
- Member of the co-ordinating panel for the new National Hospital, 1993
- Co-ordinator of Forum for Experimental Haematology, 1993-1998..
- Member of the Board of the Norwegian Cancer Society 1995 to date
- Member of the Steering committee for ”TV-aksjonen 1997” (The Norwegian Cancer Society)
- Head, Evaluation committee regarding gene therapy in Norway, appointed by ”Senter for Medisinsk Metodevurdering” (SMM 1/2000): Future role of gene therapy in the Norwegian health care.
- Member the Norwegian Research Council’s reference group regarding recruitment within medical research, 1998-1999.
- Member of Regional Scientific Committee, 18th International UICC Cancer Conference, Oslo 2000
- Member of the Postgenome Committee, Medical Faculty, University of Oslo, autumn 2000 – 2002.
- Board member “FORNY”-program, The Norwegian Research Council, 2002 – 2003.
- Head, Strategy Group for Research & Development, Helse Sør RHF, 2002.
- Member, Steering committee, National microarray consortium, 2001- date.
- Member, Coordinating Council (Samarbeidsorganet) between Helse Sør RHF, Helse Øst RHF and University of Oslo
- Member, National Research Strategy Group in Medical Research (coordinated by Health department)
Administrative experience
I have had administrative responsibility for Lab.for Immunology/Dept. of Immunology, The Norwegian Radium Hospital from 1986 to 2003. Section for Immunotherapy was included in the department in 1995 and there are now more than 30 persons employed at Department of Immunology. Approximately 2/3 of the budget for salaries, expenses and equipment are obtained from external sources. During this period I have together with Steinar Funderud had the scientific responsibility for the department. I have also been Head for the Council for Research and Development at the Norwegian Radium Hospital from 1996. The Council is an institutional council which co-ordinates research and development between the Institute for cancer research, the clinic and the industry. The Council for Research and Development is responsible for establishment and evaluation of priority areas of research and development at our institution that include high-dose therapy/stem cell therapy, detection of micrometastases, photodynamic therapy/photochemical internalisation, immunotherapy, gene therapy, clinical research unit/clinical pharmacology, radiation biology.
Research evaluation
- The Danish Cancer Society (40 million DK to cancer research, 1994)
- Evaluation committee regarding the DNR Research Foundation Cancer Research Price 1995-97.
- Member of FORNY board, The Norwegian Research Council, 2001-2003
- Member of evaluation committee of professor I position in experimental hematology , University of Copenhagen, 2003
- Opponent and member of evaluation committees for the following PhD students: dr.med. Marit Hellebostad, University o f Oslo, 1993; dr.med. Geir Erland Tjønnfjord, University of Oslo, 1995; dr.med. Magne Børset, Univerity of Trondheim 1996; dr.med. Inger Nina Farstad, University of Oslo, 1997; dr.philos. Marie Elisabeth Børrezen, University of Oslo, 1997; dr.philos. Vigdis Aas, University of Oslo, 1998; dr.scient.Trude Stensvik, University of Oslo, 1998; cand.med. Brynjar Landmark, University of Oslo, 1998; dr. philos. Ala-Al-Aoukaty, University of Oslo, 1999; dr. philos. Xiuli Wang, University of Oslo, 1999, PhD Thomas Rasmussen, University of Copenhagen, 1999, cand. med Rita Steen, University of Oslo, 1999); dr.philos Stine Ulven, University of Oslo 2000; dr.philos. Tanja Aarvak, University of Oslo 2000; dr.med.med. Ludvig Munthe, University of Oslo, 2001, dr.med. Torkel Wang, University of Oslo, 2003, Karoline Western Schjetne, UiO, 2003.
Go back
Print this page
E-mail this page
